310 related articles for article (PubMed ID: 16006665)
1. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients.
Fiala M; Lin J; Ringman J; Kermani-Arab V; Tsao G; Patel A; Lossinsky AS; Graves MC; Gustavson A; Sayre J; Sofroni E; Suarez T; Chiappelli F; Bernard G
J Alzheimers Dis; 2005 Jun; 7(3):221-32; discussion 255-62. PubMed ID: 16006665
[TBL] [Abstract][Full Text] [Related]
2. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.
Fiala M; Cribbs DH; Rosenthal M; Bernard G
J Alzheimers Dis; 2007 Jul; 11(4):457-63. PubMed ID: 17656824
[TBL] [Abstract][Full Text] [Related]
3. A novel role for SHARPIN in amyloid-β phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer's disease.
Krishnan D; Menon RN; Mathuranath PS; Gopala S
Neurobiol Aging; 2020 Sep; 93():131-141. PubMed ID: 32165044
[TBL] [Abstract][Full Text] [Related]
4. β-amyloid, microglia, and the inflammasome in Alzheimer's disease.
Gold M; El Khoury J
Semin Immunopathol; 2015 Nov; 37(6):607-11. PubMed ID: 26251237
[TBL] [Abstract][Full Text] [Related]
5. Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ
Zuroff LR; Torbati T; Hart NJ; Fuchs DT; Sheyn J; Rentsendorj A; Koronyo Y; Hayden EY; Teplow DB; Black KL; Koronyo-Hamaoui M
Front Immunol; 2020; 11():1449. PubMed ID: 32765504
[TBL] [Abstract][Full Text] [Related]
6. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
Martin E; Boucher C; Fontaine B; Delarasse C
Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
[TBL] [Abstract][Full Text] [Related]
7. Monocytes and Alzheimer's disease.
Feng Y; Li L; Sun XH
Neurosci Bull; 2011 Apr; 27(2):115-22. PubMed ID: 21441973
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.
Fiala M; Liu PT; Espinosa-Jeffrey A; Rosenthal MJ; Bernard G; Ringman JM; Sayre J; Zhang L; Zaghi J; Dejbakhsh S; Chiang B; Hui J; Mahanian M; Baghaee A; Hong P; Cashman J
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12849-54. PubMed ID: 17652175
[TBL] [Abstract][Full Text] [Related]
9. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
10. A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.
Rentsendorj A; Sheyn J; Fuchs DT; Daley D; Salumbides BC; Schubloom HE; Hart NJ; Li S; Hayden EY; Teplow DB; Black KL; Koronyo Y; Koronyo-Hamaoui M
Brain Behav Immun; 2018 Jan; 67():163-180. PubMed ID: 28860067
[TBL] [Abstract][Full Text] [Related]
11. Innate Immunity Fights Alzheimer's Disease.
Guillot-Sestier MV; Doty KR; Town T
Trends Neurosci; 2015 Nov; 38(11):674-681. PubMed ID: 26549882
[TBL] [Abstract][Full Text] [Related]
12. Dissecting Amyloid Beta Deposition Using Distinct Strains of the Neurotropic Parasite Toxoplasma gondii as a Novel Tool.
Cabral CM; McGovern KE; MacDonald WR; Franco J; Koshy AA
ASN Neuro; 2017; 9(4):1759091417724915. PubMed ID: 28817954
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy.
Zaghi J; Goldenson B; Inayathullah M; Lossinsky AS; Masoumi A; Avagyan H; Mahanian M; Bernas M; Weinand M; Rosenthal MJ; Espinosa-Jeffrey A; de Vellis J; Teplow DB; Fiala M
Acta Neuropathol; 2009 Feb; 117(2):111-24. PubMed ID: 19139910
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E Polymorphism and Oxidative Stress in Peripheral Blood-Derived Macrophage-Mediated Amyloid-Beta Phagocytosis in Alzheimer's Disease Patients.
Jairani PS; Aswathy PM; Krishnan D; Menon RN; Verghese J; Mathuranath PS; Gopala S
Cell Mol Neurobiol; 2019 Apr; 39(3):355-369. PubMed ID: 30694418
[TBL] [Abstract][Full Text] [Related]
15. Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer's disease-view from the bedside.
Fiala M
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):192-6. PubMed ID: 20205641
[TBL] [Abstract][Full Text] [Related]
16. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
[TBL] [Abstract][Full Text] [Related]
17. Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity.
Shie FS; Breyer RM; Montine TJ
Am J Pathol; 2005 Apr; 166(4):1163-72. PubMed ID: 15793296
[TBL] [Abstract][Full Text] [Related]
18. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
Walker DG; Link J; Lue LF; Dalsing-Hernandez JE; Boyes BE
J Leukoc Biol; 2006 Mar; 79(3):596-610. PubMed ID: 16365156
[TBL] [Abstract][Full Text] [Related]
19. How to get from here to there: macrophage recruitment in Alzheimer's disease.
Rezai-Zadeh K; Gate D; Gowing G; Town T
Curr Alzheimer Res; 2011 Mar; 8(2):156-63. PubMed ID: 21345166
[TBL] [Abstract][Full Text] [Related]
20. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
